戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  c-jun target genes (cyclin A, beta-PAK, and stathmin).
2 ule growth rate dependent on the presence of stathmin.
3 ed rapid dephosphorylation and activation of stathmin.
4 le played by MT-interacting proteins such as stathmin.
5 similar to one of the mechanisms utilized by stathmin.
6  but did inhibit interactions with ELK-1 and stathmin.
7 p1 and the microtubule-destabilizing protein stathmin.
8  can also covalently modify proteins such as stathmin.
9 1) and the microtubule-destabilizing protein stathmin.
10  breast cancer by regulating the function of stathmin.
11  in human breast cancer cells overexpressing stathmin.
12  was impaired by the concomitant deletion of stathmin.
13 t induces proteasome-mediated degradation of stathmin.
14 on as mechanisms for MT growth inhibition by stathmin.
15 r both mechanisms of MT growth inhibition by stathmin.
16 itchlike regulation of the MT mean length by stathmin.
17  dynamics by the signaling proteins Rac1 and stathmin.
18 ich establishes a spatial gradient of active stathmin.
19                              The oncoprotein stathmin 1 (STMN1) is upregulated in most, if not all, c
20 questration of the MT depolymerizing protein Stathmin 1 (STMN1), and we provide evidence that STAT3 m
21 paranodal microtubule destabilizing protein, stathmin 1, and the paranodal cell adhesion molecules ne
22 osphorylation sites originally identified in stathmin 1, we show here that they possess distinct phos
23 markers, vimentin, snail-2, beta-catenin and stathmin-1 (STMN1) in patient tumors.
24 s-disease transcriptomic analysis identified Stathmin-1 (STMN1), a tubulin-depolymerizing protein, as
25 reporter proteins and endogenously expressed stathmin-1 and insulin-like growth factor-1 receptor.
26 uces a redistribution of stathmin 3, but not stathmin 2, from the periphery toward the Golgi region o
27 We also show for the first time that, unlike stathmin 2, stathmin 3 is a substrate for glycogen synth
28                We have shown previously that stathmins 2 (SCG10) and 3 (SCLIP) fulfill distinct, inde
29            Therefore, we evaluated truncated stathmin-2 (STMN2) as a proxy of TDP-43 pathology, given
30 ionship of TDP-43 pathology with the loss of stathmin-2 (STMN2), an essential protein for axonal grow
31                                      Reduced stathmin-2 expression is found in neurons trans-differen
32 ion of iPSC-derived motor neurons, rescue of stathmin-2 expression restores axonal regenerative capac
33 mature polyadenylation-mediated reduction in stathmin-2 is a hallmark of ALS-FTD that functionally li
34  binding to sites within the first intron of stathmin-2 pre-messenger RNA, uncover a cryptic polyaden
35 th are microtubule modifiers, such as SCG10 (Stathmin-2).
36 ion of the neuronal growth-associated factor stathmin-2.
37  for the first time that, unlike stathmin 2, stathmin 3 is a substrate for glycogen synthase kinase (
38                               Interestingly, stathmin 3 phosphorylated at its GSK-3beta target site d
39 ion of GSK-3beta induces a redistribution of stathmin 3, but not stathmin 2, from the periphery towar
40 ow that increasing the concentration of Op18/stathmin, a component of the chromosome-mediated microtu
41 study, we report the increased expression of stathmin, a developmentally regulated tubulin-binding pr
42 t mice without an inhibitor of microtubules, stathmin, a gene enriched in BLA-associated circuitry, h
43                         Therefore, targeting stathmin, a gene product that is overexpressed in the pr
44 egulator of microtubules, we next focused on stathmin, a known ERK substrate.
45                                 Depletion of stathmin, a microtubule (MT) destabilizer, delays mitoti
46                  We found that inhibition of stathmin, a microtubule regulator that can be transcript
47                                              Stathmin, a microtubule-destabilizing protein that media
48 e stability and decreased phosphorylation of stathmin, a microtubule-destabilizing protein, at serine
49 KIS is a protein kinase that associates with stathmin, a modulator of the tubulin cytoskeleton.
50                     Here we demonstrate that Stathmin, a protein that associates with microtubules an
51 ts, and (3) contact the N-terminal region of stathmin, a protein that induces depolymerization of tub
52                                              Stathmin accumulated in the cytoplasm of 30% of spinal c
53                                Inhibition of stathmin activity by small interfering RNA-based knockdo
54 of increased vascular leak via modulation of stathmin activity.
55                                              Stathmin (also known as oncoprotein 18/Op18) is a promin
56 hreonine kinase KIS (Kinase Interacting with Stathmin, also known as UHMK1) have recently been associ
57 y sequestering tubulin; the other holds that stathmin alters microtubule dynamics by directly destabi
58 rom embryonic rat cerebral cortex identified stathmin among several differentially expressed proteins
59                                              Stathmin, an 18-kDa phosphoprotein that promotes microtu
60 tions but had no effect on interactions with stathmin, an ERK substrate whose docking site is unknown
61                           We have identified stathmin, an inhibitor of microtubule formation, as high
62 ion is exerted by modulating the activity of stathmin, an MT-destabilizing protein, and by direct bin
63 ion of the microtubule-destabilizing protein stathmin and 2) phosphorylation and inactivation of GSK-
64  highlighted three focal proteins: vimentin, stathmin and cofilin-1, belonging to or involved in cyto
65 on; and (e) hydrogen peroxide down-regulated stathmin and disrupted the cellular microtubule network.
66                                              Stathmin and fut8 were identified as downstream targets
67 we show that activated STAT3 interacted with stathmin and inhibited its microtubule-destabilizing act
68 4-HNE were associated with the activation of stathmin and microtubule catastrophe.
69 ics as measured by phosphorylation status of stathmin and microtubule-associated protein 4 (MAP4), th
70 monstrates that RSK2 directly phosphorylates stathmin and regulates microtubule polymerization to pro
71 ns in vitro and demonstrate that full-length stathmin and TTL compete for binding to tubulin and fail
72                                              Stathmin and tubulin tyrosine ligase (TTL) each form sta
73 issues, we have studied interactions between stathmin and varied tubulin polymers.
74  cylc-1 and -2, share sequence homology with stathmins and encode small, very basic proteins containi
75 number of astral microtubules was similar in stathmin +/+ and -/- MEFs.
76 wo alpha:beta tubulin dimers per molecule of stathmin), and by increasing the switching frequency (ca
77 CD79b, octamer binding factor 1, Ig H chain, stathmin, and gamma-actin.
78 , dihydrofolate reductase, thymidine kinase, stathmin, and MAP4 were down-regulated.
79                     These findings highlight stathmin as a possible biomarker of MCC and as a target
80                         These data implicate stathmin as a regulator of the microtubule network durin
81  data identify the essential mammary protein stathmin as protumorigenic and suggest it may serve as a
82                       The findings implicate stathmin as the critical molecular component linking the
83 tubule (MT) proteomic work revealed that the stathmin association with MTs is considerably reduced in
84  that RSK2 directly binds and phosphorylates stathmin at the leading edge of cancer cells.
85  and Plk1 are likely regulated downstream of stathmin, because the combination of stathmin knockdown
86                                 We show that stathmin binds tightly to Dolastatin-10 tubulin rings, w
87 m of any direct action is mysterious because stathmin binds to microtubules very weakly.
88 ofluorescence microscopy, we also found that stathmin binds to purified microtubules along their leng
89                     The direct inhibition of stathmin by CCNU is likely a contributing factor.
90  the cellular microtubule-associated protein stathmin by its known association with the cellular phos
91                           Phosphorylation of stathmin by RSK2 reduced stathmin-mediated microtubule d
92                                 Silencing of stathmin by small interfering RNA (siRNA) in mutant p53
93 of microtubule regulatory proteins that like stathmin can bind to soluble tubulin and depolymerize mi
94            The results firmly establish that stathmin can increase the steady-state catastrophe frequ
95     Taken together, our results suggest that stathmin can promote catastrophe by direct action on pro
96 tributed within motoneurons and that loss of Stathmin causes impaired NMJ growth and stability.
97 genitors were transfected using a myc-tagged stathmin cDNA and were allowed to differentiate.
98 only active in interphase; overexpression of stathmin-CFP did not impact metaphase microtubule nuclea
99   In mouse mammary epithelial cells, loss of stathmin compromised the trafficking of polarized protei
100                            For a homogeneous stathmin concentration in the absence of Rac1, we find a
101 al simulations to determine the steady-state stathmin concentration, the mean MT length distribution,
102 ormatic analyses, we show that p27(kip1) and stathmin conjunctly control activation of the MAPK pathw
103              In MEFs, the relative amount of stathmin corresponded to genotype, where cells heterozyg
104 e kidney epithelial (LLCPK) cells expressing stathmin-cyan fluorescent protein (CFP) or injected with
105  in in vitro assays and cells overexpressing stathmin-cyan fluorescent protein.
106                  siRNA-induced repression of stathmin decreased cell proliferation, viability and clo
107 -/-) VSMCs fully restored the phenotype, and stathmin-deficient mice demonstrated reduced lesion form
108 S-/- VSMCs fully restored the phenotype, and stathmin-deficient mice demonstrated reduced lesion form
109 ss induce proteome-wise alterations, such as stathmin degradation and disorganization of the cell mic
110 ustained expression of constitutively active stathmin delayed cytoplasmic maturation (ie, glycoprotei
111   These results demonstrate the mechanism of stathmin-dependent control of MT dynamics, Rho signaling
112                                          The stathmin-dependent regulation of nucleation is only acti
113 ent of Plk1 to the centrosome was delayed in stathmin-depleted cells, independent of MTs.
114                                              Stathmin depletion reduced the activity of CDC25 and its
115 zation to the centrosome required MTs, while stathmin depletion spread its localization beyond that o
116 lymerizing MTs with nocodazole abrogates the stathmin-depletion induced cell cycle delay; in this stu
117 imic curved tubulin protofilaments, and that stathmin depolymerizes stabilized protofilament-rich pol
118                                    Moreover, stathmin depresses TTL tubulin tyrosination activity in
119                 Plk1 was inhibited by excess stathmin, detected in in vitro assays and cells overexpr
120 oncomitant deletion of stathmin in p27(kip1)/stathmin double-KO mice, suggesting that a CDK-independe
121                 To explore the importance of stathmin down-regulation during megakaryocytopoiesis, we
122                 We explored the functions of stathmin down-regulation in activated macrophages by gen
123    These data define a required function for Stathmin during synapse maintenance in a model system in
124                                              Stathmin, encoded by the signature gene STMN1, was an ac
125 ed to genotype, where cells heterozygous for stathmin expressed half as much stathmin mRNA and protei
126 hese findings suggest that the inhibition of stathmin expression and function may be useful in limiti
127                             We conclude that stathmin expression in demyelinating disorders could hav
128                                      Reduced stathmin expression in neuroblastoma cells significantly
129                                              Stathmin expression is critical to maintain oriented cel
130                    We show that decreases in stathmin expression lead to significant decreases in mal
131                         Moreover, inhibiting stathmin expression significantly reduced transendotheli
132  impaired in MKs in which down-regulation of stathmin expression was prevented.
133  phosphorylation, each phosphoprotein of the stathmin family fulfilling distinct and specific roles i
134  bound by stathmin or by the SLD of RB3, two stathmin family members that have been extensively studi
135  protein) is a neuron specific member of the stathmin family of microtubule regulatory proteins that
136           We identify STMN2, which encodes a stathmin family protein and is down-regulated in PD brai
137                                              Stathmin family proteins play major roles during the var
138 pecific cellular locations of members of the stathmin family.
139                                  Remarkably, stathmin(-/-) females have an enhancement in social inte
140 ow that the deficiency in fear processing in stathmin(-/-) females leads to improper threat assessmen
141 ficiency is observed in maternal behavior of stathmin(-/-) females: they lack motivation for retrievi
142 e, we selected for modeling the complex of a stathmin fragment with two tubulin heterodimers with two
143                               CopN displaces stathmin from preformed stathmin-tubulin complexes, indi
144                                  We examined stathmin function in two cell systems: mouse embryonic f
145 ne, enabling future genetic investigation of Stathmin function with potential relevance to the cause
146          These data support a model in which stathmin functions in interphase to control the partitio
147  by maternal nutrient restriction: caveolin, stathmin, G-1 cyclin, alpha-actin, titin, cardiac ankyri
148 lated from embryos +/+, +/-, and -/- for the stathmin gene and porcine kidney epithelial (LLCPK) cell
149 model system in which there is only a single stathmin gene, enabling future genetic investigation of
150                                 We show that stathmin-GFP overexpression impacts MT stability, impair
151 generating a stable cell line overexpressing stathmin-GFP.
152                                              Stathmin has been studied intensively because of its ass
153       The microtubule-destabilizing protein, stathmin, has recently been shown to mediate neuroblasto
154    These results suggest either that TTL and stathmin have a partially overlapping footprint on the t
155                 In physiological conditions, stathmin immunoreactivity was observed in polysialic aci
156 icate that an important regulatory action of stathmin in cells may be to destabilize microtubule minu
157 n, implicating a pivotal inhibitory role for stathmin in classically activated macrophages.
158                            Overexpression of Stathmin in HeLa cells was associated with collapse of m
159                            Downregulation of stathmin in KIS(-/-) VSMCs fully restored the phenotype,
160                            Downregulation of stathmin in KIS-/- VSMCs fully restored the phenotype, a
161  We therefore sought to establish a role for stathmin in malignant glioma cell motility, migration, a
162                           On the other hand, stathmin in mature OLs may indicate cell stress and poss
163 l role of the microtubule-associated protein stathmin in MCPyV ST-mediated microtubule destabilizatio
164                                      Loss of stathmin in MMTV-Delta16HER2 transgenic mice decreased t
165  mice is reverted by concomitant deletion of stathmin in p27(kip1)/stathmin double-KO mice, suggestin
166 his controversy and investigated the role of stathmin in primary human MKs.
167 em to prevent physiologic down-regulation of stathmin in primary MKs.
168 the involvement of the MT-associated protein stathmin in the mediation of agonist-induced permeabilit
169             These results suggest a role for stathmin in the migration of newborn neurons in the adul
170  by siRNA, suggesting participation of these stathmins in granule formation or maturation.
171                The disassembly of the NMJ in stathmin includes a predictable sequence of cytological
172                                              Stathmin increased the minus end catastrophe frequency a
173                                   Absence of stathmin induced alterations in mitotic spindle orientat
174 pping footprint on the tubulin dimer or that stathmin induces a tubulin conformation incompatible wit
175                                              Stathmin is a developmentally regulated cytosolic protei
176                                              Stathmin is a highly conserved MT-regulatory protein tha
177                                              Stathmin is a microtubule-destabilizing protein ubiquito
178                                              Stathmin is a ubiquitous microtubule destabilizing prote
179                                              Stathmin is an important regulator of microtubule polyme
180   These studies indicate that suppression of stathmin is biologically important for MK maturation and
181 constitutively active Rac1 at the cell edge, stathmin is deactivated locally, which establishes a spa
182                          In the early phase, stathmin is dephosphorylated, enhancing its microtubule-
183                                              Stathmin is known to form a tight 1:2 complex with tubul
184 ial task dependent on the hippocampus, where stathmin is not normally expressed.
185 e regulated by cytosolic stathmin, while the stathmin is regulated by Rac1 at the membrane.
186                   We therefore conclude that stathmin is required for the induction of LTP in afferen
187                        Op18 (Oncoprotein 18, Stathmin) is a mitotic regulator that is highly expresse
188 e results, together with the decrease of one Stathmin isoform, suggest a role of the protein in Golgi
189                           Kinase-interacting stathmin (KIS) is a growth factor-dependent nuclear kina
190 Transfection of CECs with kinase-interacting stathmin (KIS) siRNA was performed.
191                      Kinase interacting with stathmin (KIS) targets 2 key regulators of cell prolifer
192                      Kinase interacting with stathmin (KIS) targets 2 key regulators of cell prolifer
193  at Ser10 was mediated by kinase-interacting stathmin (KIS), confirmed with siRNA to KIS, and phospho
194         In this study, we report that female stathmin knock-out (STM KO) mice are unable to nurse the
195 ream of stathmin, because the combination of stathmin knockdown and inhibition of Aurora A and Plk1 w
196                    The protective effects of stathmin knockdown were observed in vivo in the mouse 2-
197  from amygdala slices that are isolated from stathmin knockout mice show deficits in spike-timing-dep
198                                 In contrast, stathmin level had a significant effect on microtubule n
199                                    Increased stathmin level in LLCPK cells, sufficient to reduce micr
200 re and after the down-regulation of cellular stathmin levels and in the absence and presence of suble
201                           However, sustained stathmin levels in differentiating OLs, because of overe
202 ucleation rate from centrosomes, where lower stathmin levels increased nucleation and higher stathmin
203 thmin levels increased nucleation and higher stathmin levels reduced nucleation.
204                     In MS patients, however, stathmin levels were elevated in 2',3'-cyclic nucleotide
205 , we show that there is a global decrease in stathmin levels, an MT catastrophe protein, in activated
206      Aged wild-type mice show impairments in stathmin levels, changes in microtubule stability and Gl
207 o test the biological relevance of increased stathmin levels, primary OL progenitors were transfected
208 aspanin 2 (Tspan2), peroxiredoxin 4 (Prdx4), stathmin-like 2 (Stmn2), myelin oligodendrocyte glycopro
209         Here, we design and characterize new stathmin-like domain (SLD) proteins that sequester tubul
210 tered expression of adducin-alpha, pallidin, stathmin-like-2, and synaptojanin-2 binding protein.
211 hus, the signature or its components such as stathmin may be clinically useful tests for stratificati
212 tion back to control levels, indicating that stathmin may influence these processes in neuroblastoma
213            We hypothesized that by reversing stathmin-mediated depolymerization of microtubules or by
214                     We previously identified stathmin-mediated mechanisms of resistance to antimicrot
215  Phosphorylation of stathmin by RSK2 reduced stathmin-mediated microtubule depolymerization.
216 st excessive neointima formation by opposing stathmin-mediated VSMC migration and that VSMC migration
217 monstrated by results showing that CTLs from stathmin(-/-) mice displayed defective MTOC polarization
218 to the synapse, allowing it to phosphorylate stathmin molecules near the immunological synapse.
219 n in the Rac- and Cdc42-dependent PAK1/2 and stathmin molecules.
220 rozygous for stathmin expressed half as much stathmin mRNA and protein as wild-type cells.
221            In particular, we consider a Rac1-stathmin-MT pathway in which the growth and catastrophe
222 ion of either wild type or a phospho-mimetic stathmin mutant (4E) made defective in tubulin binding r
223 GluA2 endocytosis rescues memory deficits in stathmin mutant and aged wild-type mice.
224 le expression of a phosphorylation-deficient stathmin mutant exacerbated thrombin-induced EC barrier
225                Arrest of the larval stage in stathmin mutants also reveals a degree of progressive in
226                    In addition, we show that stathmin mutants display evidence of defective axonal tr
227                                              Stathmin mutations disrupt changes in microtubule stabil
228 hese clones (cardiac alpha-actin, cyclin G1, stathmin, NADH dehydrogenase subunit 2, titin and prosta
229     Our results indicate that the effects of stathmin on dynamic instability are strongly but differe
230 ylation of the individual serine residues of stathmin on microtubule dynamic instability have not bee
231                           Phosphorylation of stathmin on one or more of its four serine residues (Ser
232                               Oncoprotein 18/Stathmin (Op18) is a microtubule-destabilizing protein t
233 ion of the microtubule destabilizing protein stathmin/Op18 in the nascent axon and that this event is
234 nt from two, the number of tubulins bound by stathmin or by the SLD of RB3, two stathmin family membe
235                      We found that targeting stathmin or wee-1 expression with RNA interference can i
236 )/M progression, respectively, and sensitize stathmin-overexpressing breast cancer cells to paclitaxe
237 he trans-Golgi protein SCLIP (STMN3) and its stathmin paralog SCG10 (STMN2) for functional study.
238                    Furthermore, knockdown of stathmin partially restored cell-cycle regulation and ac
239                          Therefore, the RSK2-stathmin pathway represents a promising therapeutic targ
240  yielded a binding stoichiometry of 1 mol of stathmin per approximately 14.7 mol of tubulin in the mi
241 ein levels, caused by a lack of KIS-mediated stathmin phosphorylation at serine 38 and diminished sta
242              Supporting an important role of stathmin phosphorylation in T cell activation, we showed
243  the physiological relevance of KIS-mediated stathmin phosphorylation in VSMCs are unknown.
244  the physiological relevance of KIS-mediated stathmin phosphorylation in VSMCs are unknown.
245                                 Furthermore, stathmin phosphorylation positively correlated with RSK2
246   These observations lead us to propose that stathmin promotes catastrophe by binding to and acting u
247                            One model is that stathmin promotes microtubule catastrophe indirectly, an
248  phosphorylation at serine 38 and diminished stathmin protein degradation.
249                                 We show that Stathmin protein is widely distributed within motoneuron
250 omigratory phenotype resulted from increased stathmin protein levels, caused by a lack of KIS-mediate
251 disassembly is induced following the loss of Stathmin protein.
252 n fluorescent protein (CFP) or injected with stathmin protein.
253                                              Stathmin proteins can thus be either regulated locally o
254                  Furthermore, overexpressing stathmin reduces complement receptor 3-mediated phagocyt
255                  These data demonstrate that stathmin regulates mitotic entry, partially via MTs, to
256                       In several cell types, stathmin regulates the partitioning of tubulin between u
257 ion, in neuroblastoma cells highlighted that stathmin regulates transendothelial migration through RO
258                         Reduction or loss of stathmin resulted in increased microtubule polymer but l
259                In this study we investigated stathmin's contribution to the metastatic process and po
260                    Moreover, we suggest that stathmin's minus-end preference results from interaction
261 preference results from interactions between stathmin's N terminus and the surface of alpha-tubulin t
262 show that these mechanisms could account for stathmin's observed activities in vitro, but that both t
263                                              Stathmin's sequestration activity is well established, b
264 er, overexpression of phospho-mimetic mutant stathmin S16D significantly rescued the decreased invasi
265                            Although CopN and stathmin share no detectable sequence identity, both inf
266              Here we analyzed the effects of stathmin singly phosphorylated at Ser(16) or Ser(63), an
267                                              Stathmin steady-state catastrophe-promoting activity was
268                                              Stathmin (STMN), a cytoplasmic microtubule-destabilizing
269 ough proteomics analysis, we determined that stathmin (STMN1) is affected by EBV-miR-BART6-3p and LOC
270                            Here we show that stathmin strongly destabilizes microtubule minus ends in
271  with its ability to destabilize minus ends, stathmin strongly increased the treadmilling rate of bov
272 eins dihydropyrimidinase-related protein and stathmin suggested mechanisms for rapid cytoskeletal reo
273                                     Finally, stathmin suppression in neuroblastoma cells significantl
274                               In conclusion, stathmin suppression interferes with the metastatic proc
275                                              Stathmin suppression preserved the MT network against th
276                                              Stathmin suppression significantly reduced neuroblastoma
277 ce of the fact that the lateral diffusion of stathmin tends to weaken the effects of Rac1 on the dist
278                  For tubulin sequestering by stathmin, this establishes a bistable switch with two st
279 oxiredoxin 1 and down-regulation (by 25%) of stathmin through proteasome-mediated degradation; and (e
280 strongly reduced or abolished the ability of stathmin to bind to and sequester soluble tubulin and it
281   These findings highlight the importance of stathmin to the metastatic process and its potential as
282 5) and Ser(38) did not affect the binding of stathmin to tubulin or microtubules or its catastrophe-p
283 the presence of a 1:5 initial molar ratio of stathmin to tubulin yielded a binding stoichiometry of 1
284 to tubulin and fail to make a stable tubulin:stathmin:TTL triple complex in solution.
285 rotubule-destabilizing activity by promoting stathmin-tubulin binding, whereas in the late phase thes
286 bulin strongly inhibits formation of the 1:2 stathmin-tubulin complex (>3.3 kcal/mol), while ER-07634
287       CopN displaces stathmin from preformed stathmin-tubulin complexes, indicating that the proteins
288 strophe frequency approximately 13-fold at a stathmin:tubulin molar ratio of 1:5.
289                                              Stathmin was also pathway-pharmacodynamic in vitro and i
290        In addition, using mass spectrometry, stathmin was identified as the main component of a speci
291                    For catastrophe-promoting stathmin, we do not find bistability.
292                          Increased levels of stathmin were confirmed by Western blot analysis of norm
293                      Mutations in Drosophila stathmin were isolated in two independent genetic screen
294 argeting wee-1 led to the phosphorylation of stathmin, which is known to attenuate its activity.
295 the MT growth rate is inhibited by cytosolic stathmin, which, in turn, is inactivated by Rac1.
296 ophe rates of MTs are regulated by cytosolic stathmin, while the stathmin is regulated by Rac1 at the
297 ealed that the tubulin-destabilizing protein Stathmin, whose expression also confers resistance to pa
298                               In contrast to stathmin, whose major action on dynamics is to destabili
299    Protein profiling showed dysregulation of Stathmin with a marked decrease of its most acidic and p
300 ntimitotic peptides mimic the interaction of stathmin with tubulin.

 
Page Top